Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: All I can say is 336 must be one heck of a patent to be re-examed again!

The challengers to a reexam request canot appeal a USPTO decision. This is their way to try and usurp the process by putting in these continuous reexam requests. Collectively, they would rather spend millions doing this than paying inevitable billions they owe us. When will they learn that resistance is futile? Probably when the next settlement is announced. It will be a shot across the bow.

WOW

Share
New Message
Please login to post a reply